Quoin Pharmaceuticals (QNRX) Treasury Shares (2017 - 2023)
Quoin Pharmaceuticals (QNRX) posted Treasury Shares of $2.9 million for Q3 2023, little changed sequentially from $2.9 million in Q2 2023, and little changed YoY from $2.9 million in Q3 2022.
Quoin Pharmaceuticals (QNRX) Treasury Shares (2017 - 2023) Analysis & Trends
Quoin Pharmaceuticals has reported Treasury Shares for 7 years, with the latest figure at $2.9 million in Q3 2023.
- Quarterly Treasury Shares changed 0.0% year-over-year to $2.9 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $2.9 million (changed 0.0% YoY) and the FY2022 annual result came in at $2.9 million, changed 0.0% from the prior year.
- Treasury Shares was little changed at $2.9 million in Q3 2023 per QNRX's latest filing, from $2.9 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.9 million in Q4 2020 and troughed at $2.6 million in Q2 2019.
- A 5-year average of $2.9 million and a median of $2.9 million in 2020 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2020 and 2021: Treasury Shares grew 2.88% in 2020, then changed 0.0% in 2021.
- Over 5 years, Treasury Shares stood at $2.6 million in 2019, then grew by 10.93% to $2.9 million in 2020, then changed by 0.0% to $2.9 million in 2021, then changed by 0.0% to $2.9 million in 2022, then changed by 0.0% to $2.9 million in 2023.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.9 million, $2.9 million, and $2.9 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.93 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.93 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Dec 31, 2020 | 2.93 Mn |
| Dec 31, 2020 | 2.93 Mn |
| Jun 30, 2020 | 2.72 Mn |
| Jun 30, 2020 | 2.72 Mn |
| Jun 30, 2019 | 2.64 Mn |
| Jun 30, 2019 | 2.64 Mn |